Image provider Jakub Porzycki/NurPhoto via Getty / Futurism
Novo Nordisk, the Danish maker of the diabetes injection Ozempic and its sister weight-loss drug Wigoby, plans to cut prices amid shortages and intensifying competition.
Novo CEO Carsten Munk Knudsen Reuters reportacknowledged that “given increased volume and competition, real net prices in the United States will fall.”
Currently, both Ozmepic and Wegobee cost patients an eye-watering $1,000 or more a month, and many insurance companies still refuse to cover them, forcing patients to pay higher prices. Either that or you don’t have to pay. Many people seeking these drugs, which use the active ingredient semaglutide to mimic the feeling of fullness in the intestines, turn to other glucagon-like peptide 1 agonists, such as Zepbound and Mounjaro from Eli Lilly, or from Sketch. I’m looking for an unregulated version. Online pharmacy.
Due to high demand, widespread shortages Results for several years after both drugs were on the market.However, as new paper inside Journal of the American Medical Association To elaborate, semaglutide is actually very cheap to produce.
News of the apparent price cuts for these drugs comes just as the Federal Trade Commission announced it is challenging Novo’s so-called “junk patents” on Ozempic and other drugs that have become exorbitantly popular. It’s the first step in a long road to allowing generic injectable drugs. .
This also comes amidst mixed financial news for the Denmark-based pharmaceutical company. Inventory was low Even though Ozempic and Wegovy saw a huge sales boom this week.
in the same way Quarterly financial reportNovo reported sales of $9.35 billion in the first quarter of 2024 alone and announced that a whopping 25,000 new patients started taking Wegovy. Hit week. According to the company, Ozempic’s sales increased by 42%, while Wegovy’s increased by a whopping 106%.
Nevertheless, the Danish company’s stock price fell more than 3% after the conference call. fast company report In his earnings report, Knudsen blamed the decline on announcements to increase supply and lower prices.
News of the planned price reduction, the total amount of which has not yet been reported, is definitely good news for those who were looking to get their hands on these meme-worthy drugs.keep stirring mixed emotions in the era of body positivity.
Weight loss drug details: Tracy Morgan says she actually managed to gain weight on Ozempic with her superhuman eating abilities
